Gatipotuzumab

N/A

Report date: 2025/09/29 20:01:14

Base Information

Drug NameGatipotuzumab
Drug Alias NamePankoMab-GEXGT-MAB-2.5-GEX
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsSolid tumoursFallopian Tube NeoplasmsPeritoneal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandRomaniaRussian Federation +[9] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNemodGlycotope Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycotope Gmbh
Active IndicationsN/A
Inactive IndicationsSolid tumoursFallopian Tube NeoplasmsPeritoneal Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia